Literature DB >> 10459162

High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions.

P K Chan1, W H Li, M Y Chan, W L Ma, J L Cheung, A F Cheng.   

Abstract

The prevalence of human papillomavirus (HPV) among 332 Hong Kong Chinese women with abnormal Papanicolaou smears were determined by polymerase chain reaction and restriction fragment length polymorphism analysis. The overall HPV positive rate was 44.3% with 18.6% (16/86) for normal/inflamed cervices, 36.4% (32/88) for condyloma, 64.7% (33/51) for cervical intraepithelial neoplasia grade 1 (CIN 1), 37.9% (11/29) for CIN 2, 68.3 (41/60) for CIN 3, and 77.8% (14/18) for carcinoma. Double HPV infection was detected in 17 of the 147 positive samples, with a significantly higher proportion in patients with normal or inflamed cervices than those with CIN or carcinoma (31.3% vs 10.5%, P =.029). The six most commonly identified genotypes were HPV 16 (33.3%), HPV 58 (23.8%), HPV 11, 18, 31 (8.8% each), and HPV 33 (6.8%). The worldwide uncommon genotype HPV 58 was found to be the second most common genotype detected in patients with cervical carcinoma (6 of 18 patients). HPV 58 infection showed a significant association with CIN/carcinoma (odds ratio [OR] = 3.98; 95% confidence interval [CI] = 1.22-14.35) and a significant trend of increase in prevalence with increasing severity of cervical lesion (chi(2) = 5.84; P =.016). Among Hong Kong Chinese women with abnormal cervical cytology, the detection of HPV 58 carried a positive predictive value of 68.6% for a cervical lesion of CIN 1 or higher severity. The high prevalence of HPV 58 among Chinese women, particularly in patients with carcinoma, has an implication on the design of HPV detection methods and the development of vaccines. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459162

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

1.  Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors.

Authors:  P K Chan; M Y Chan; W W Li; D P Chan; J L Cheung; A F Cheng
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Asymptomatic genital infection of human papillomavirus in pregnant women and the vertical transmission route.

Authors:  Dongrui Deng; Liangzhen Wen; Wen Chen; Xiazhen Ling
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 3.  Human papillomavirus in Ethiopia.

Authors:  Awoke Derbie; Daniel Mekonnen; Gizachew Yismaw; Fantahun Biadglegne; Xaveer Van Ostade; Tamrat Abebe
Journal:  Virusdisease       Date:  2019-04-20

4.  Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk.

Authors:  Tatiana Dantas Rodrigues Laprano; Erika Hardy Lemos; Lia Moreira Pinto Cunha; José Eleutério Júnior; Rosiane Alves de SousaTeles; Silvia Helena Barem Rabenhorst
Journal:  Tumour Biol       Date:  2014-04-30

5.  Machine Learning Interpretation of Extended Human Papillomavirus Genotyping by Onclarity in an Asian Cervical Cancer Screening Population.

Authors:  Oscar G W Wong; Idy F Y Ng; Obe K L Tsun; Herbert H Pang; Philip P C Ip; Annie N Y Cheung
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

6.  T-cell response to human papillomavirus type 58 L1, E6, And E7 peptides in women with cleared infection, cervical intraepithelial neoplasia, or invasive cancer.

Authors:  Paul K S Chan; Shih-Jen Liu; T H Cheung; Winnie Yeo; S M Ngai; Jo L K Cheung; Pele Chong; Stephen Man
Journal:  Clin Vaccine Immunol       Date:  2010-07-28

7.  The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae.

Authors:  Hye-Lim Kwag; Hyoung Jin Kim; Don Yong Chang; Hong-Jin Kim
Journal:  J Microbiol       Date:  2012-11-04       Impact factor: 3.422

8.  Human papillomavirus type 58: the unique role in cervical cancers in East Asia.

Authors:  Paul Ks Chan
Journal:  Cell Biosci       Date:  2012-05-09       Impact factor: 7.133

9.  Cervical Cancer Screening for the Reluctant - HPV Testing of Air-Dried Vaginal Discharge.

Authors:  Tommy R Tong; Rae Wai-Nang Yau; Olivia Wai-Hing Chan; Vivian Yu; Joyce Wing-Sze Lo; Tat-Chong Chow; Billy Wai-Hon Chan; Kam-Cheong Lee
Journal:  Int J Biomed Sci       Date:  2006-12

Review 10.  Laboratory and clinical aspects of human papillomavirus testing.

Authors:  Paul K S Chan; María Alejandra Picconi; Tak Hong Cheung; Lucia Giovannelli; Jong Sup Park
Journal:  Crit Rev Clin Lab Sci       Date:  2012 Jul-Aug       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.